NCT03079050View on ClinicalTrials.gov

An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

July 30, 2017

Study Completion Date

July 30, 2017

Conditions
GERDProton Pump Inhibitor
Interventions
DRUG

Dexlansoprazole 60 MG

This drug will be given to 34 random patients during the 2nd, 3rd, and 4th weeks of the month of Ramadan to assess its ability to relieve GERD symptoms

Trial Locations (1)

Unknown

American University of Beirut - Medical Center, Beirut

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

American University of Beirut Medical Center

OTHER